Tag: ICH Q9

Risk-Based Qualification Program for Lab Equipment: A Regulatory Guide

In modern pharmaceutical laboratories, compliance is more than documentation—it’s about ensuring that every instrument used in testing and production delivers accurate, traceable, and reproducible results. With global regulatory expectations evolving, the emphasis has shifted from a one-size-fits-all approach to a risk-based qualification framework for lab equipment. This article explores how pharma and regulatory professionals can…

Equipment and Calibration, Instrument Qualification

Checklist for Requalification After Equipment Changes

In a GMP-regulated pharmaceutical facility, equipment validation is not a one-time task. Regulatory bodies expect requalification after certain changes to ensure ongoing fitness-for-purpose. This checklist-style guide provides global pharma professionals with a complete breakdown of what must be considered when requalifying equipment—especially in stability testing contexts—after planned or unplanned changes. When Is Equipment Requalification Required?…

Equipment and Calibration, Validation of Stability Testing Equipment

Risk-Based Validation Approach for New Stability Chambers

As pharmaceutical companies expand or modernize their stability testing infrastructure, the need to validate new stability chambers becomes inevitable. Traditionally, validation followed a one-size-fits-all model, but today’s regulatory bodies encourage a risk-based validation (RBV) approach—especially for equipment qualification. This tutorial outlines how to implement a compliant, efficient RBV framework for new chambers. What is Risk-Based…

Equipment and Calibration, Validation of Stability Testing Equipment

Deviation Classification Systems in GMP Environments

Deviation classification in GMP environments is a critical component of quality assurance. A well-structured deviation classification system ensures that all non-conformances are properly categorized, investigated, and resolved based on their potential impact. This article explores how deviation types are defined, documented, and utilized to maintain compliance with regulatory standards such as USFDA, EMA, and ICH…

Deviation and OOS Handling in Stability Testing, Pharmaceutical Quality and Practices

ICH Q9 Integration in Stability Planning

Stability studies are a critical component of pharmaceutical product lifecycle management. With global regulatory bodies emphasizing a risk-based approach, integrating ICH Q9 Quality Risk Management (QRM) principles into stability planning has become essential for compliance, cost-efficiency, and scientific justification. This tutorial outlines a systematic way to implement ICH Q9 in designing, executing, and documenting stability…

Pharmaceutical Quality and Practices, Risk-Based Approaches to Stability Testing

Applying ICH Q9 to Risk Management in Stability Protocols

In the realm of pharmaceutical development and regulatory compliance, risk-based thinking is no longer optional—it is expected. The International Conference on Harmonisation’s ICH Q9 guideline provides the framework for applying Quality Risk Management (QRM) across the product lifecycle. In this article, we explore how ICH Q9 principles can and should be integrated into stability testing…

ICH Stability Guidelines (Q1A–Q1E, Q8, Q9, etc.), Regulatory Guidelines